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Optical mapping of neuronal 
activity during seizures in zebrafish
L. Turrini  1, C. Fornetto2, G. Marchetto2, M. C. Müllenbroich1,3, N. Tiso  4, A. Vettori4,  
F. Resta1, A. Masi5, G. Mannaioni  5, F. S. Pavone1,3,6 & F. Vanzi1,2
Mapping neuronal activity during the onset and propagation of epileptic seizures can provide a 
better understanding of the mechanisms underlying this pathology and improve our approaches to 
the development of new drugs. Recently, zebrafish has become an important model for studying 
epilepsy both in basic research and in drug discovery. Here, we employed a transgenic line with pan-
neuronal expression of the genetically-encoded calcium indicator GCaMP6s to measure neuronal 
activity in zebrafish larvae during seizures induced by pentylenetretrazole (PTZ). With this approach, 
we mapped neuronal activity in different areas of the larval brain, demonstrating the high sensitivity 
of this method to different levels of alteration, as induced by increasing PTZ concentrations, and the 
rescuing effect of an anti-epileptic drug. We also present simultaneous measurements of brain and 
locomotor activity, as well as a high-throughput assay, demonstrating that GCaMP measurements can 
complement behavioural assays for the detection of subclinical epileptic seizures, thus enabling future 
investigations on human hypomorphic mutations and more effective drug screening methods. Notably, 
the methodology described here can be easily applied to the study of many human neuropathologies 
modelled in zebrafish, allowing a simple and yet detailed investigation of brain activity alterations 
associated with the pathological phenotype.
Epilepsy is one of the most common neurological disorders worldwide and is characterized by recurrent spon-
taneous bursts of neuronal activity, known as seizures. Genetic mutations, such as various ion channelopathies1, 
alteration of neuronal migration, or protein degradation defects in neurons (e.g. Angelman syndrome) can be 
frequently associated with epilepsy2, 3. Moreover, epileptic seizures can occur as a consequence of a variety of 
insults, such as brain tumours, injury, stroke, or neurodegeneration. Despite a wide range of anti-epileptic drugs 
(AEDs) currently available for treatment of epilepsy4, approximately 35% of patients fail to respond adequately 
to therapy5, 6. In the last years, most of the research on AEDs has been performed using rodent models. These 
models have significantly contributed to increase our comprehension of epilepsy but suffer from limitations for 
the identification of new AEDs, regarding, for example, the throughput of drug screening and the time required to 
generate new transgenic lines to model specific epileptic pathogenic mechanisms. Therefore, to further increase 
our understanding of basic mechanisms underlying epilepsy and to develop novel treatments new experimen-
tal approaches and new animal models7, 8 are needed. Over the past decade, zebrafish (Danio rerio) has rapidly 
emerged as an important model organism in genetics and in biomedical research, with strong applications in 
translational neurosciences9. There are considerable advantages in utilizing zebrafish for the study of neurobiol-
ogy, neuropathology and for the development of new therapeutic approaches. Zebrafish, in fact, exhibits external 
embryonic development (making it easy to manipulate), high fecundity rate (providing large and homogeneous 
samples that are ideal for high-throughput screenings), and a fully sequenced genome, with about 70% of human 
genes having at least one orthologue in zebrafish10, making it suitable for the implementation of models of human 
pathologies, including epilepsy. Moreover, the brain of this teleost is characterized by regions structurally similar 
to those in the mammalian brain and with similar neurochemistry11, 12. Finally, the optical transparency of larvae 
during the first week of development enables in vivo imaging and is undoubtedly one of the strongest points of 
this animal model both in basic research and in the field of neurological disease analysis.
Several recent studies revealed that pentylenetetrazole (PTZ) can be successfully used to induce seizure-like 
behaviour in zebrafish larvae, making this pharmacological approach suitable to study several kinds of human 
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epilepsy in this animal model13, 14. Also, many genes involved in epilepsy have been investigated in zebrafish mod-
els, including mutants showing resistance to seizures15, 16, hypersensitivity to convulsant drugs or even spontane-
ous seizures17. Thus far, epileptic seizures have been detected and characterized in zebrafish either as behavioural 
alterations or by means of direct electrographic recordings. Behavioural measurements rely on the recording of 
swimming activity by time-lapse videos and tracking of the larva position in time13, 18, 19. During seizures, larvae 
exhibit a variety of behaviours classified in different epileptic stages13. This type of measurements has been used to 
characterize chemically-induced convulsions and to screen potential anti-convulsant drugs, capable of reversing 
the effects of PTZ20.
However, a detailed study of the mechanisms of epilepsy requires measuring the neuronal activity underlying 
seizures. The most used method to this end is the electrographic recording of activity in large areas of the larval 
brain via extracellular field recordings. These studies have proved effective in detecting brain electrical activity 
and its alterations, which correlate with seizures13, 18, 21. However, a full comprehension of the genesis and propa-
gation of seizures would ultimately require measuring activity at cellular resolution. The measurement of activity 
with high spatial resolution would most likely also improve the efficacy of drug screenings for specific compounds 
by discarding those molecules acting on undesired target brain areas.
An important advancement in the measurement of neuronal activity has been represented by the develop-
ment of optical methods based on fluorescent calcium indicators, taking advantage of the correlation between 
intracellular calcium concentration and frequency of spiking. Fast and sensitive genetically-encoded calcium 
indicators (such as GCaMP22, 23) represent a powerful tool for the investigation of neuronal dynamics with up to 
single action potential sensitivity22. Moreover, genetically targeting the expression of the indicator allows selecting 
the population of cells probed (for example neurons versus glial cells, or subpopulations of neurons within the 
central nervous system).
Compared to electrophysiological recordings, in which an electrode is typically introduced into the tissue, the 
use of light has several advantages. Most prominently, optical measurements are much less invasive and allow the 
parallel measurement of activity on large populations of neurons (up to the whole brain) with a resolution that 
can probe single cells. Indeed, in recent years, the use of GCaMP in zebrafish has been proven highly valuable for 
the measurement of neuronal activity across the whole brain of the larva with the capability of identifying about 
80% of its 100,000 neurons24, 25.
Here, we present optical recordings of whole brain activity in zebrafish larvae expressing the 
genetically-encoded calcium indicator GCaMP6s under the pan-neuronal promoter elavl326. These measure-
ments are employed to quantify and map brain activity during the treatment with the well-characterized con-
vulsant agent PTZ. The method proves highly effective in detecting seizures of different intensities and patterns 
as induced by different PTZ concentrations, probing the involvement of different brain areas in different condi-
tions. We also demonstrate a combined measurement of optical neuronal activity measurements and locomotor 
behaviour of the larva, proving that optical measurements are more sensitive than behavioural assays in detect-
ing increased activity linked with convulsive or subclinical epileptic seizures. Finally, we implement GCaMP6s 
measurements of brain activity in a high-throughput assay, demonstrating that combined calcium indicator fluo-
rescence and swimming behaviour measurements can be performed on a large number of larvae undergoing dif-
ferent pharmacological treatments. This approach opens the way to screening methods in which the behavioural 
information is complemented with an actual measurement of neuronal activity, allowing a more complete view 
of drug candidates’ effectiveness.
Results
GCaMP6s optical measurements show basal and PTZ-altered activity in the zebrafish 
brain. For this work, a zebrafish transgenic line was generated (as described in Methods) to express 
GCaMP6s22 in all CNS neurons. Pan-neuronal expression in the Tg(elavl3:GCaMP6s) zebrafish encephalon pro-
vided a strong signal that maps throughout the whole larval brain, allowing us to clearly distinguish different 
anatomical areas of the encephalon such as the telencephalon, the optic tectum, the cerebellum and the medulla 
(Fig. 1a). During the analysis of brain activity, the larvae were mounted under the microscope in a setup allowing 
solution exchanges (see Methods), so that each larva could be monitored in control conditions for about ten min-
utes, before adding PTZ at the desired concentration. This experimental protocol enabled the direct measurement 
of the onset of the compound activity as well as its steady effect at prolonged exposures. Figure 1b shows a typical 
experiment in which 15 mM PTZ is added after 11 minutes of control recording. The ΔF/F0 trace (see Methods) 
clearly shows an increase of the baseline developing early after PTZ addition. Compared to control (where few 
small peaks of spontaneous activity are visible, with a maximum amplitude of about 0.4), the effect of PTZ devel-
oped gradually over about ten minutes and reached a steady convulsion activity with large and regularly paced 
calcium spikes. In the trace shown in Fig. 1b, during the 50–60 minutes following the onset of PTZ effect, activity 
was regularly paced, with ΔF/F0 maximum amplitudes of 2–3. With more prolonged exposure to PTZ even larger 
bursts became evident (ΔF/F0 up to 5–6).
The data shown in Fig. 1b demonstrate the high sensitivity of our recording method to the convulsant effects 
of PTZ. Moreover, these experiments demonstrate that different stages of convulsions can be recognized in the 
calcium trace, depending on both amplitude and frequency of the fluorescence peaks. It is also interesting to con-
sider the signal baseline and its dynamics: due to projection of the fluorescence signal on one plane and the inte-
gration over the whole brain, the measured baseline can indeed be interpreted as a measurement of basal brain 
activity of the larva. Our measurements are very sensitive to this parameter, as demonstrated by the sharp and 
rapid increase of the baseline upon exposure to PTZ. To further test this sensitivity, we performed measurements 
of activity upon treatment with tricaine, an anaesthetic commonly used to immobilize zebrafish larvae. Figure 1c 
shows the marked decay of basal neuronal activity associated with the tricaine treatment. The use of a specific 
blocker of voltage-dependent Na+ channels (Tetrodotoxin, TTX) also induced complete suppression (after about 
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35 minutes of treatment) of the calcium signal in our measurements in the presence of 15 mM PTZ (Fig. 1d), 
demonstrating that the signal is entirely due to neuronal firing activity. Thus, GCaMP integrated measurements 
are effective in monitoring both basal activity and dynamics due to alterations such as seizures or drug treatments.
GCaMP6s fluorescence measurements are sensitive to different PTZ concentrations. We next 
characterized the response of zebrafish larvae to different PTZ concentrations. Figure 2a shows GCaMP6s record-
ings in 0 (control), 1, 2.5, 7.5 and 15 mM PTZ. The figure shows a clear dependence of both peak amplitudes 
and frequencies on PTZ concentration: at 1 and 2.5 mM PTZ, the peaks amplitudes are only slightly larger than 
control; on the other hand, at 7.5 and 15 mM PTZ we observed a marked increase in amplitude of the spikes and 
the appearance of regularly paced patterns of activity. Particularly at 15 mM PTZ the ΔF/F0 signal displayed 
long (about 5 minutes) and very large (ΔF/F0 up to 4–5) increases consisting of clusters of closely spaced spikes 
(Fig. 2a, inset). Each burst is followed by a period of low activity before a new burst appears. We observed some 
variability in the latency for appearance of these characteristic convulsive clusters of seizures (as visible from a 
comparison between Fig. 1b and the trace at 15 mM in Fig. 2a), but the periodicity of the convulsive and rest 
periods was remarkably reproducible across larvae.
Observation of the data in Fig. 2a shows that GCaMP measurements are sensitive to a range of activity altera-
tions as induced by different PTZ concentrations. Our recordings enabled quantitative analysis of calcium activity 
in terms of both amplitude and frequency. Based on automated data analysis (see Methods) we identified each 
peak and measured its amplitude and the frequency of firing in the recordings. Figure 2b-c show the peak ampli-
tudes and frequencies measured at different PTZ concentrations in the range between 0 and 15 mM. The ΔF/F0 
peak fluorescence (Fig. 2b) exhibits a linear dependence on PTZ concentration (R = 0.992). Firing rates (Fig. 2c), 
on the other hand, do increase with PTZ concentration but in a nonlinear manner. In the figures, measurements 
are also reported for larvae that had been pre-incubated with Valproic Acid (VPA, 5 mM) for one hour before 
the treatment with PTZ (at 15 mM). The data clearly show that the anti-epileptic effect of this drug (one of the 
most commonly used in the treatment of epilepsy in humans) was measured extremely well by our method, since 
the ΔF/F0 peak amplitude and frequencies measured upon treatment with this drug were not distinguishable 
from the control levels. The linear response observed for the ΔF/F0 signal over the range of PTZ concentrations 
Figure 1. Brain activity recording with GCaMP6s. (a) Fluorescence image of the encephalon of a 4 dpf larva 
expressing GCaMP6s under elavl3 promoter. Scale bar: 100 µm. The four main zebrafish brain regions used for 
further analysis in the paper are highlighted (Telencephalon, blue; Optic tectum, orange; Cerebellum, yellow; 
Medulla, purple). (b) Time trace of fluorescence (ΔF/F0, see Methods for detail) in control conditions and 
after addition of 15 mM PTZ (at the time indicated). The fluorescence data are integrated over the whole brain 
of the larva and sampled at 5 Hz. The inset shows a shorter time interval of the trace to better display calcium 
peak shape and regularity. (c) ΔF/F0 trace of an experiment in which tricaine (160 mg/L) was added at the time 
indicated and the subsequent decay of activity was monitored. The ΔF/F0 values become negative after tricaine 
addition since the F0 reference level was measured in control conditions (see Methods for details). (d) ΔF/F0 
trace showing sharp brain activity decay in a larva simultaneously treated with 15 mM PTZ and 5 μM TTX. 
After approximately 35 min upon drugs application, TTX action totally suppressed neuronal seizure activity 
induced by PTZ.
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explored is interesting in the frame of studying mutations, which have been associated with epilepsy but may not 
lead by themselves to evident behavioural phenotypes. More generally, the method lends itself to the character-
ization of sub-threshold alterations of activity, due to genetic mutations or pharmacological treatments. Using 
PTZ as a standard in the field, we assessed the simplest and most robust method to quantify the effects of this 
compound on larval brain activity. For application of GCaMP6s activity measurements in a high-throughput 
assay (see below) we tested whether a simple time-averaged fluorescence over the whole recording in a given 
condition would be effective in detecting alterations of brain activity in a concentration-dependent manner. The 
data are shown in Supplementary Figure S1 and demonstrate that this simpler method is applicable to an analysis 
requiring less detail but faster processing such as demanded in high-throughput assays.
Correlation analysis among brain regions and muscle movements. One of the main advantages of 
optical imaging with respect to the use of an electrode is the capability of simultaneously monitoring activity in 
different brain regions. Furthermore, with the very large field of view of our microscope we could image the whole 
larva, thus conducting simultaneous measurements of brain activity and tail movement (see Supplementary 
movie 1; the tail was free to move due to the method adopted for mounting the larva on the slide, as described 
in Methods). Imaging of the tail and its movements was facilitated by the fluorescence signal from GCaMP6s 
expressed in neurons of the spinal cord. We analysed fluorescence dynamics in four distinct brain regions: tel-
encephalon, optic tectum, cerebellum and medulla. Figure 3 shows typical results obtained for the recording 
of brain activity and tail movement at 0, 1 and 15 mM PTZ concentration. The general patterns of activity and 
peak amplitudes reflect the results shown in Fig. 2 for the signal averaged over the whole brain. Distinguishing 
the different brain regions, however, allows some interesting observations. During spontaneous activity (CTRL, 
Fig. 3a) we noticed that the activities in the optic tectum, cerebellum and medulla were well correlated, while 
the telencephalon exhibits independent patterns. Moreover, while the larger peaks in the three caudal regions 
of the brain correlated with large movements of the tail, telencephalon activity was not always linked with large 
movements. Figure 3d shows an enlarged part of the fluorescence and tail movement traces, demonstrating that 
in this condition most of the tail movements are brief, small amplitude beats consisting of a single small tail swing. 
These movements (also shown in Fig. 3g) can be classified as “beat and glide” movements27, and are not paired 
with measurable changes of fluorescence (most likely due to the loss of sensitivity caused by integrating the signal 
over large encephalic areas in wide field imaging). Compared to control, at 1 mM PTZ (Fig. 3b) we observed that 
telencephalon correlation with the caudal regions increased, even though some instances of independent peaks 
persisted. As shown also by the data in Fig. 2, at this PTZ concentration, we observed the appearance of some 
peaks with a larger amplitude than control peaks (the dotted line indicates the maximum value of ΔF/F0 typically 
reached in control recordings). These peaks can therefore be attributed to the alterations induced by PTZ. It is 
interesting to notice that, some of these peaks were associated with large tail movements (that would be con-
ducive to swimming, if the larva were free to swim), but many others (highlighted by arrowheads in the figure) 
were not associated with any tail movement or, at most, with very small tail deflections that would not produce 
detectable movements in behavioural assays. Indeed we noticed that additionally to the infrequent but large tail 
swings (Fig. 3b,h), at 1 mM PTZ concentration, the larva exhibited frequent small tail movements associated 
with detectable changes in the ΔF/F0 signal (Fig. 3e). We noticed that, compared to control movements, these 
are more clustered and exhibit a larger number of tail beats per event. These movements can thus be classified 
Figure 2. Comparison of the effects of different PTZ concentrations on brain activity. (a) ΔF/F0 is plotted as a 
function of time for control conditions and increasing PTZ concentrations as indicated. Upper left panels show 
images acquired at the points indicated during the recording at 15 mM PTZ, demonstrating the large dynamic 
range of the signal and lack of saturation even at the highest recorded levels. The inset on the upper right 
shows a single cluster of closely spaced calcium spikes occurring at 15 mM PTZ and displayed on a magnified 
time scale. ΔF/F0 calibaration bar: 100%. (b) Mean amplitude of peaks detected over one hour registration 
for each larva recorded (see Methods for details about automatic peak detection). The red symbol represents 
measurements performed on larvae treated with 15 mM PTZ after a pre-incubation of one hour in 5 mM 
Valproic acid (VPA). The linear regression through the PTZ-only measurements (dashed line) produces a slope 
of 0.037/mM, Pearsons’s r = 0.992. Number of larvae measured: 6 (0 mM), 7 (1 mM), 5 (2.5 mM), 6 (7.5 mM), 
7 (15 mM), 3 (15 mM + VPA). Error bars are s.e.m. and where not visible are smaller than the symbol size. (c) 
Mean peak frequency as a function of PTZ concentration. The number of larvae is the same as in panel b.
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as “dart” movements27. At 15 mM PTZ (Fig. 3c) we observed the complete synchronicity of activity in the four 
brain regions, the appearance of very large, regularly paced peaks of activity which are associated with larger tail 
movements, i.e. with the stage III13 convulsive swimming detected also in behavioural assays. We also noticed a 
correlation between peak intensity and the amplitude of tail movement, with higher peaks being associated with 
powerful swimming bouts (Fig. 3c,f,i) and lower peaks with smaller tail fluctuations. Supplementary movies 2–4 
show examples of the three types of tail movements described in the three conditions tested. Despite vigorous tail 
movements, the agarose-embedded head of the larva remained very stable during the measurements, thus avoid-
ing potential movement artefacts (see methods for more details). The stability of the sample can be appreciated in 
the Supplementary movies 1–4, enabling measurements in the absence of paralyzing agents, with the advantage of 
allowing combined fluorescence and tail movement measurements such as those shown in Fig. 3. Supplementary 
Fig. S2 shows ΔF/F0 traces obtained after paralyzing the larva with d-tubocurarine, demonstrating the same fea-
tures shown by the data in the absence of paralyzing agent (Fig. 3).
We next analysed the amplitudes and frequencies of both calcium and tail signals. Figure 4a-b show the mean 
peak amplitude and firing rate, respectively, measured in the different brain regions at 0, 1 and 15 mM PTZ. We 
can observe that during spontaneous activity cerebellum and medulla exhibit slightly larger peaks, while firing 
rates are quite similar across the brain, with the optic tectum having a slightly higher rate than cerebellum and 
medulla. The introduction of PTZ, on the other hand, induced a concentration-dependent imbalance of the 
caudal regions (optic tectum, cerebellum and medulla) compared to telencephalon. The imbalance was evident 
both in terms of amplitudes (with a very large increase at 15 mM PTZ) and rates. Fig. 4c-d show the effects of PTZ 
on tail movement. Overall, the distributions of tail movement amplitudes (Fig. 4c) demonstrate that PTZ most 
evidently induced seizures at 15 mM concentration, characterized by large tail swings (with amplitudes larger 
than 0,4 mm and up to 2.2 mm on our scale, where neither control nor 1 mM PTZ exhibited any event), These 
convulsive bursts are followed by a static phase, accounting for the lower average tail beat frequency in 15 mM 
PTZ compared to control and 1 mM (Fig. 4d).
Figure 3. Simultaneous measurement of brain activity and tail movement. (a) Time trace of tail movement 
(black line) and fluorescence (ΔF/F0) analysed in control conditions (0 mM PTZ) for four brain regions color-
coded as in Fig. 1a. The traces show correlations between fluorescence peaks and tail movements for optic 
tectum, cerebellum and medulla, while the telencephalon exhibits some degree of activity not correlated with 
tail movement. (b-c) Tail movement and brain activity analysed as in panel a at 1 and 15 mM PTZ, respectively. 
The dashed lines show a ΔF/F0 level of 0.4 corresponding to the highest peaks typically measured in control 
conditions. The arrowheads in panel b highlight peaks overcoming the 0.4 level and not corresponding to 
large tail movements. (d-e-f) Expanded time scale traces of the fragment indicated by the asterisk in a, b and c, 
respectively. Each panel shows movement and fluorescence traces (color-coded as in panels a-c) corresponding 
to a typical tail movement observed in the corresponding condition. (g-h-i) Fluorescence images of head-
restrained larvae (see Methods) in 0, 1 and 15 mM PTZ. Images are maximum intensity projections over a time 
interval of 10 min, chosen during typical locomotor activity of the tested condition. Panels h and i are displayed 
with gamma = 0.4 to avoid saturation in the encephalon and still have good contrast on the tail. Scale bar 
500 µm.
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We then analysed the correlations between neuronal activities in different brain regions and with tail move-
ment. We first considered the correlation between telencephalon and medulla, which was observed to be low in 
control condition and low PTZ concentrations (see Fig. 3). Fig. 5a shows correlation in one typical recording 
performed without PTZ. The data confirmed the presence of a significant fraction of telencephalon activity not 
correlated with medulla, as quantitatively demonstrated also by the low correlation coefficient (R = 0.35). In order 
to assess the correlation of any brain activity with tail movement, we identified points in the fluorescence trace 
occurring during movement and plotted them with green symbols in the figure, while red symbols represent 
brain activity not associated with movement. We noticed that the independent telencephalon activity was not 
associated with any tail movement, while neuronal spiking occurring in the telencephalon synchronously with 
that of medulla was associated with locomotor activity. Figure 5b-c show the same measurement performed at 1 
and 15 mM PTZ, respectively. The data show that, with increasing PTZ concentrations, there was a progressive 
reduction of the fraction of independent telencephalon activity, which was measured by an increasing correlation 
coefficient (R = 0.61 and R = 0.89 at 1 and 15 mM PTZ, respectively). At 1 mM PTZ, a population of data points 
corresponding to medium levels of correlation were still visible and maintained the property of spontaneous tel-
encephalon activity, i.e. they were not functionally linked with tail movement. At 15 mM PTZ, on the other hand, 
the correlation between telencephalon and medulla was high and most of the neuronal activity was associated 
with tail movement. Figure 5d-f show correlation measurements with tail movement analysis for cerebellum and 
medulla. In this case, we could observe complete correlation of the two areas in all conditions (R = 0.94, 0.98 and 
0.98 at 0, 1 and 15 mM PTZ, respectively) and a tight link between activity in these areas and locomotor activity.
A systematic characterization of the correlation of activity across all the four brain areas (for left and right 
hemisphere, Supplementary Fig. S3) confirmed the observation that increasing PTZ concentrations induce sei-
zures consisting of highly correlated activity across the whole brain. At low (1 mM) PTZ concentration and in 
control conditions, on the other hand, we could observe the progressive loss of correlation along the rostro-caudal 
axis, with the telencephalon being the region which less correlates with the others. In all conditions, we observed 
a high correlation between left and right side of each region. We also observed that after onset of PTZ effect, cor-
relations maintained their characteristic patterns for the whole duration of our measurements. These results are 
Figure 4. Distributions of brain activity and tail movement. (a-b) Bars represent mean peak amplitude and 
mean peak frequency, respectively, in the four brain regions highlighted in Fig. 1a, for the three different 
conditions tested (0, 1 and 15 mM PTZ). Error bars: s.e.m. Number of larvae measured: 3 for each experimental 
condition. (c-d) Distribution of tail movement amplitude and mean frequency for the three experimental 
conditions tested (one larva per condition). Error bars in d represent the uncertainty of a Poisson’s distribution.
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in line with previously observed whole-brain activation induced by PTZ28, 29 and with the common use of PTZ at 
10–15 mM concentration to induce generalized seizures in the larva.
High-throughput combined fluorescence and behavioural recordings. One of the main advan-
tages of zebrafish is the possibility of performing high-throughput drug screenings. The data shown in Figs 2–3 
demonstrate that measurements of neuronal activity can complement behavioural measurements by providing 
information on activity alterations not always linked to altered swimming behaviour of the larva. To this purpose, 
we implemented fluorescence measurements in a wide-field configuration at low magnification, enabling imaging 
over a large area (~50 cm2). With this optical system, we could simultaneously measure GCaMP6s fluorescence 
and larva position from 61 larvae in parallel, testing ten different experimental conditions with statistics of 5–6 
larvae per condition. We chose to reproduce some of the conditions tested in the paper (i.e. 0, 1 and 15 mM PTZ 
treatment, Valproate, Tricaine and TTX treatments in the presence of 15 mM PTZ), together with a test on the 
effects of two compounds acting on synaptic transmission and previously shown to alter PTZ-induced seizures 
as measured with electrical recordings13: kynurenate (a non-specific blocker of postsynaptic glutamate receptors, 
which was shown to reduce seizure amplitudes) and Baclofen (a GABAB receptor agonist, which was shown to 
increase the amplitude of seizures). Supplementary movie 5 shows a 13 minutes segment of the recording. For 
an overall view of larva behaviour and fluorescence in each well, we produced a maximum intensity projection 
(MIP) of 45 minutes (Fig. 6a), after one hour of drugs exposure. The figure immediately demonstrates the effects 
of increasing PTZ concentrations, as visible from an increased motility of the larvae at 1 mM PTZ (wells 7–12) 
compared to control (wells 1–6) and a further increase of motility, associated with a very large increase of flu-
orescence at 15 mM PTZ (wells 13–18). Introduction of Baclofen potentiated the fluorescence signal both at 1 
(wells 19–24) and 15 mM PTZ (25–30). Tetrodotoxin (wells 31–36), on the other hand, completely suppressed 
neuronal activity, even in the presence of 15 mM PTZ, as show in Fig. 1d, with consequent decrease of signal and 
larva paralysis. The effect of kynurenate (wells 39–43) was not apparent in the MIP analysis but became more 
evident in a subsequent quantitative analysis of ΔF/F0 and movement (Fig. 6b-c). An important point to note in 
this type of assay is that some compounds (for example kynurenate) might display significant fluorescence at the 
wavelengths employed for GCaMP6s excitation and detection, as demonstrated by the background measured in 
the well containing only kynurenate (well 38) compared to fish water (well 37). Valproate showed its effectiveness 
in the MIP measurement (wells 44–49) where it decreased both larva motility and fluorescence in the presence 
of 15 mM PTZ. D-tubocurarine (wells 50–55) caused larva paralysis, but unfortunately often caused the death of 
the larvae at the concentration used. Finally, tricaine (wells 56–61) showed its anaesthetic effect in terms of both 
Figure 5. Correlations of brain activity in different regions with locomotor activity. Correlation plots of ΔF/F0 
for chosen pairs of brain regions in control, 1 and 15 mM PTZ. Correlations are shown between telencephalon 
and medulla (panels a-c) and between cerebellum and medulla (panels d-f). Red and green symbols represent 
fluorescence data corresponding to resting and swimming times, respectively (see Methods). In panels a and 
b it is evident the presence of a subset of data characterized by telencephalon activity not associated with 
medulla activity (panel a) or associated with only low levels of medulla activity (panel b); all those data points 
correspond to time intervals in which no tail movement takes place. Measurements shown are from the 
recording performed on one larva.
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reduced fluorescence and motility of the larvae. The results of the high-throughput assay were quantified also by 
measuring the average ΔF/F0 (Fig. 6b) and larva swimming velocity (Fig. 6c) in all conditions tested. Velocities 
were calculated from trajectories shown in Supplementary Fig. S4.
Discussion
The development of new AEDs, capable of successfully treating the relevant fraction (about 35%) of patients not 
responsive to currently available drugs, would highly benefit from the possibility of performing high-throughput 
screenings and drug refinement on animal models accurately portraying the molecular framework of specific 
epileptogenic processes in those patients. In this regard, zebrafish represents, for many reasons, an ideal model to 
pursue this goal. It is a vertebrate model with sufficient similarity in its brain architecture and neurochemistry to 
allow comparisons with the human brain11, thus enabling a study of seizure dynamics in different regions and on 
different neuronal populations. Moreover, the zebrafish genome is characterized by the presence of orthologues 
of at least 70% of all human genes and is easy to be genetically manipulated for the production of transgenic lines 
reproducing mutations found to be linked with epilepsy in humans10. These features have made this animal model 
very prominent in recent years for the study of epilepsy and for the screening and development of new AEDs16. 
Current approaches are mainly based on electrophysiological measurements and behavioural assays. The former 
are very informative on overall brain activity but lack spatial discrimination, thus failing to provide detailed 
information on the localization of the epileptic foci and the dynamics of propagation of seizures. Recently a 
multi-electrode system has been developed capable of addressing long-term electrical measurements in parallel 
on several zebrafish larvae and providing independent measurements of electrical activity in up to five regions 
of the larva encephalon along the rostro-caudal axis30. Behavioural assays, on the other hand, are very simple to 
conduct and easily lend themselves to high-throughput screenings, and have been, indeed, successfully used to 
identify new potential AEDs20, 31, 32. These assays rely on the detection of large swimming bouts and locomotor 
alterations in zebrafish larvae induced by either specific mutations (for example mind bomb33) or chemical treat-
ments (typically PTZ) and screening for compounds capable of rescuing normal locomotor phenotype. Although 
quite simple and effective, we argue that this method may suffer from two limitations. Firstly, it detects only sig-
nificant locomotor seizures and might miss sub-threshold or pre-epileptic events; secondly, it provides a positive 
cue for compounds that may have, for example, a strong anaesthetic or paralyzing effect and would, therefore, be 
undesirable as anti-epileptic therapeutic agents.
To overcome the limitations of current methods, here we describe an approach based on employing a trans-
genic line expressing GCaMP6s in all neurons and directly measuring neuronal activity in larvae treated with 
PTZ. This compound was chosen since it has been widely proven to be a good way to induce convulsions in 
zebrafish that are considered a good model for epileptic seizures in humans. The data in Figs 1 and 2 demonstrate 
that fluorescence recordings show characteristic changes in ΔF/F0 peaks with increasing amplitudes for increas-
ing PTZ concentrations in the range tested. We also showed that the simple measurement of the average ΔF/F0 
Figure 6. High-throughput combined fluorescence and behavioural assay. (a) Maximum intensity projection 
of a 13 minute segment of the recording. Well content: 1–6 control, 7–12 1 mM PTZ, 13–18 15 mM PTZ, 19–24 
1 mM PTZ + 50 μM Baclofen, 25–30 15 mM PTZ + 50 μM Baclofen, 31–36 15 mM PTZ + 5 μM Tetrodotoxin, 
37 fish water, 38 fish water + 2 mM Kynurenate, 39–43 15 mM PTZ + 2 mM kynurenate, 44–49 15 mM 
PTZ + 5 mM Valproate, 50–55 15 mM PTZ (after pre-incubation in 2 mM d-tubocurarine for 10 minutes before 
starting the measurement), 56–61 15 mM PTZ + 160 mg/L Tricaine. (b) Average ΔF/F0 and (c) swimming 
velocity for the different conditions tested. Error bars: s.e.m.
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signal integrated over time and over the whole larva brain is sufficient to detect alterations induced by PTZ even 
at very low (1 mM) concentrations. A full characterization of PTZ effects on zebrafish larvae has demonstrated a 
concentration-dependent variety of behaviours classified in different stages13: an increase of swimming activity 
with respect to control (stage I), whirlpool-like circular swimming (stage II) and clonus-like convulsions with 
loss of posture (stage III). The PTZ concentrations normally employed to induce generalized seizures in zebrafish 
larvae are in the range of 10–15 mM. It has been shown13 that lower concentrations delay the onset of seizures 
and, below a given threshold, for example at 2.5 mM, full convulsions (stage III) are never reached, while stages 
I and II can still be observed. Thus, these low PTZ concentrations can be used to induce a mild or pre-epileptic 
state in the zebrafish larva. This sub-threshold state may also mimic the effects induced by genetic alterations not 
capable by themselves to induce seizures but contributing to determine a genetic epileptogenic background. In 
our work, it is interesting to notice that, in the presence of 1 mM PTZ, some fluorescence spikes could be observed 
with amplitudes higher than the typical maximum amplitude of control measurements, as shown by the dotted 
line in Fig. 3. Some of these peaks (highlighted by the arrowheads in Fig. 3c) were not conducive to tail move-
ment or only caused very small oscillations that would not lead to a locomotion detectable in behavioural assays. 
Thus, it is evident that the direct measurement of brain activity represents a powerful means for characterizing 
sub-threshold alterations. This sensitivity is essential to dissect contributions of individual mutations and develop 
specific drugs for each of them and, therefore, to test drugs with much higher effectiveness.
Compared to electrophysiology, optical measurements have the advantage to be non-invasive and to provide 
full mapping of brain activity. Previously, PTZ was investigated with organic calcium indicators and two-photon 
microscopy in Xenopus laevis tadpoles to measure neuronal activity at single cell level34. A genetically-encoded 
FRET-based calcium indicator was first applied in zebrafish by Tao et al. for the study of PTZ-induced seizure 
propagation in the larva brain35. Recently GCaMP-expressing zebrafish larvae were used in a microfluidic system 
with two-photon excitation to measure neuronal and locomotor response to chemical stimuli36.
The measurements shown in Figs 1b and 2a lend themselves to a direct comparison between optical and 
electrophysiological measurements. The regularly-paced large ΔF/F0 peaks seen during seizures at 15 mM PTZ 
(Fig. 2a) were remarkably similar to the results obtained with electrical measurements30 and to the envelope of the 
data measured with the FRET-based genetically encoded calcium indicator35. Moreover, the data shown in Fig. 2c 
for spiking frequencies compares well with data published at the same PTZ concentration with electrophysiologi-
cal recordings13. We also performed a direct comparison between optical and electrophysiological measurements 
by simultaneously recording GCaMP6s fluorescence and electrical activity with an extracellular electrode placed 
in the optic tectum. The data shown in Supplementary Fig. S5 demonstrate an excellent sensitivity of the ΔF/F0 
signal averaged over the whole larva brain with the tectal field recording. It can be noticed that the fluorescence 
signal monitors both ictal and inter-ictal activity. The correspondence between our optical measurements and 
the data obtained with electrophysiological methods confirms the effectiveness of calcium measurements for 
monitoring seizures in zebrafish larvae, at least in a time domain compatible with the dynamics of available 
genetically-encoded calcium indicators.
In this study, the choice of wide-field over confocal or two-photon imaging is due to the time resolution 
we wanted to achieve in calcium imaging, in order to detect the fast dynamics of calcium peaks in the whole 
brain. Moreover, the large field of view allowed simultaneous measurements of brain activity and tail movement. 
However, implementing fast volumetric imaging methods24 will allow extending this study down to the cellular 
level, without significant loss in temporal resolution. We thus consider the demonstration conducted in this study 
as the basis for complementing electrophysiological information with optical measurements, providing more 
detailed data on activity mapped at single brain region level (Figs 3–5) and, in the future, down to single neurons, 
enabling a better understanding of seizure onset and propagation.
The simplicity and speed of wide-field imaging comes with loss of the optical sectioning capability of the larva 
brain, as would be attainable with confocal microscopy. This might especially affect the attribution of fluorescence 
coming from a given region in the image plane to specific brain structures, which are located at different depths 
within the brain. Considering the projection of the whole brain of the larva onto a single plane in wide field imag-
ing, we assessed potential bleed-through of spurious fluorescence from adjacent regions (especially for deeper 
structures) due to photon scattering in the brain volume. Supplementary Figure S6 shows this characterization, 
demonstrating that all features and details of the larva encephalon as observed in the confocal image are well 
visible also in the wide field image. Moreover, we find that cross-talk caused a deviation of measured fluorescence 
by less than 10% from ideal measurements. We notice that in any case, based on the data shown in Supplementary 
Figure S6, this small amount of possible cross-talk only regards optic tectum and telencephalon, as expected from 
their relative position and 3D structure; however, our data (Fig. 3a) demonstrate true uncorrelated activity of 
telencephalon without significant cross-talk of this signal with the optic tectum.
Another significant advantage of optical measurements is the ease of implementation of high-throughput 
screening methods37 in which brain activity is measured in an array of larvae undergoing different treatments. 
Here we present a demonstration of high-throughput measurement of fluorescence and motility of 61 larvae 
undergoing a battery of ten different conditions. Considering the resolution of the optical system (sufficient to 
image the whole larva and track it adequately for behavioural measurements), the sCMOS detector area and the 
LED power, it is easy to imagine a scalability of this measurement to a much larger number of wells beyond the 
proof-of-principle shown here.
Moreover, optical measurements can be combined with other techniques (including electrophysiological, 
behavioural assays, optogenetic neuronal stimulation and/or inhibition) to facilitate a more extensive and pow-
erful study of epileptic seizures in zebrafish and expand the potential of this model for the comprehension of this 
pathology in its diverse genetic variants as well as for the screening and development of new AEDs.
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Finally, the method (and its high-throughput drug screening applications) lends itself to the study of neuronal 
activity alterations in any other neuropathology for which a genetic or pharmacological model is available in 
zebrafish.
Materials and Methods
Zebrafish transgenesis and maintenance. We generated a zebrafish Tg(elavl3:GCaMP6s) line using 
a Tol2 construct with elavl3 promoter that drives the expression of the genetically encoded calcium indicator 
GCaMP6s in all neurons26. One-cell stage zebrafish embryos were injected with the Tol2 transgene construct 
together with the transposase mRNA. Mosaic transgenic fish displaying a strong fluorescence at 24 hpf were 
selected and raised to adulthood. Offspring from one single selected founder was finally used to establish a new 
stable transgenic line used for the experiments.
Zebrafish of the Tg(elavl3:GCaMP6s) strain were maintained according to standard procedures38. Larvae 
were raised in 0.003% N-phenylthiourea (P7629, Sigma) to inhibit melanogenesis, avoiding the formation of skin 
pigments.
The Tol2-elavl3-GCaMP6s plasmid was a gift from Dr. Misha Ahrens (Addgene plasmid # 59531)
All experiments were carried in accordance to Italian law on animal experimentation (D.L. 4 March 2014, 
n.26), under authorization n. 407/2015-PR from the Italian Ministry of Health.
Zebrafish larvae preparation. Each 4 dpf Tg(elavl3:GCaMP6s) zebrafish larva was transferred into a reaction 
tube containing 1.5% (w/v) low gelling temperature agarose (A9414, Sigma) in fish water (150 mg/L Instant 
Ocean, 6.9 mg/L NaH2PO4, 12.5 mg/L Na2HPO4, pH 7.2), kept at 38 °C. The larva was then taken up with a syringe 
in a glass capillary (O.D. 1.5 mm); after gel polymerization, the agarose cylinder was gently extruded from the 
capillary and laid on a microscope slide. In this phase, care was taken to orient the embedded larva with its dorsal 
portion facing upwards. A small drop of melted agarose was then placed on the head portion of the larva in order 
to immobilize the head in the precise orientation chosen. Next, the agarose cylinder below the yolk was cut off 
with a scalpel and removed, in order to free the tail. This procedure not only allows measurements of tail move-
ment but also improves the quality of encephalic imaging by preventing vibrations otherwise transmitted through 
the agarose cylinder (see Supplementary movies 6–8, showing that movements associated with convulsions, visi-
ble in the fully embedded larva, are drastically reduced by freeing the tail, almost as effectively as with a paralysing 
agent). A flow chamber was then assembled by attaching a coverslip to the microscope slide with double-sided 
tape (1.5 mm thick). In every experiment the chamber was initially filled with fish water.
To perform high-throughput measurements we designed a black PVC multi-well plate composed of 61 cylin-
drical wells (diameter: 7 mm; depth: 5 mm; volume: ~200 μL) arranged in an hexagonal geometry. The material 
chosen to build the multi-well plate had the advantage of both being inert and offering a dark background for 
fluorescence measurements. Each 4 dpf Tg(elavl3:GCaMP6s) zebrafish larva was transferred into one of the 61 
wells with an appropriate volume of fish water. After 20 min of habituation, 10 min of control recording were per-
formed and then drug stock solutions were added to each of the 61 wells to obtain the desired final concentrations 
in 180 μL final total volume. Measurements were then run for 2 hours, a time sufficient for all the tested drugs to 
exert their action.
Chemicals. Stock solutions of pentylentetrazole (PTZ; P6500, Sigma-Aldrich), valproic acid (VPA, P4543, 
Sigma-Aldrich), tricaine (A5040, Sigma-Aldrich), kynurenic acid (KYN, ab120256, Abcam), tetrodotoxin (TTX) 
and Baclofen (BAC) were prepared by dissolving in milliQ water (at 100 mM concentration for PTZ, VPA and 
KYN; 4 g/L for tricaine; 2 mM for TTX; 10 mM for Baclofen;). The final concentrations used in the experiments 
were obtained by diluting each stock in fish water. D-tubocurarine (D-TC; 93750, Sigma-Aldrich) was dissolved at 
2 mM concentration directly in fish water and used by pre-incubating the larvae for 10 min before measurements.
Wide-field fluorescence microscope. Imaging of the mounted larvae was performed using a custom-made upright 
fluorescence microscope. We imaged either the entire zebrafish larva (using EC Plan-NEOFLUAR 2.5x/0.085 
M27, Carl Zeiss Microscopy) or only the encephalic region (with EC Plan-NEOFLUAR 5x/0.16 M27, Carl Zeiss 
Microscopy). Fluorescence was excited in wide-field configuration using an LED with emission centred at 470 nm 
(M470L3, Thorlabs), followed by an excitation band-pass filter (469/35 nm, FF01–469/35, Semrock). The epi-
fluorescence detection was implemented with a dichroic mirror (DC FF495-DI02, Semrock) and an emission 
band-pass filter (525/39 nm, MF525-39, Thorlabs). The fluorescence signal was recorded with a sCMOS camera 
(OrcaFLASH 4.0, Hamamatsu Photonics) with 16-bit dynamic range.
To perform high-throughput measurements the excitation LED was equipped with a diffuser to produce an 
even illumination over an area of about 50 cm2, covering all the multi-well plate. In order to image such a large 
area, a wide-angle lens (MVL8M23, Thorlabs) with 8 mm focal length was mounted directly on the camera.
Brain activity recordings. Imaging was performed with the camera operating at 5 Hz (200 ms exposure time); 
each measurement was composed of a 10-minute control recording (during which the larva was kept in fish 
water), followed by addition of the drug solutions at the desired concentration and subsequent recording for 30 
to 120 minutes.
When performing measurements on the whole larva to obtain data on tail movement along with fluorescence, 
the camera was operated at 33 Hz frame rate with 5 ms exposure time (chosen to guarantee sharp images of the 
tail even during fast movements).
High-throughput measurements were performed operating the camera at 5 Hz (200 ms exposure time).
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Data analysis. In each wide-field experiment, the GCaMP6s fluorescence signal from the whole larval enceph-
alon or from different brain regions (telencephalon, optic tectum, cerebellum, medulla) was measured using 
ImageJ, by manually selecting the desired region of interest (ROI). The ROI’s mean fluorescence intensity for each 
time point was then calculated and, after background subtraction, the values obtained were further processed 
using a custom Matlab script to obtain the ΔF/F0 signal (following ref39) as described below.
The baseline for every time point (F0) was calculated (using Matlab function msbackadj with a running win-
dow and a step size of 2000 and 13333 points for 5 Hz and 33 Hz recordings, respectively) and subtracted from the 
fluorescence signal (F), thus producing ΔF. These values were then normalized by dividing them by the baseline 
itself, obtaining ΔF/F0.
The traces shown in Fig. 1b-c were processed differently, to highlight the dynamics of the basal brain activity in the 
experimental conditions shown. The mean fluorescence intensity of each 10 min control recording was calculated and 
used as F0 in the ΔF/F0 calculation of each trace. In this way, the trace was not flattened by running baseline subtraction.
Automatic peak detection was performed on ΔF/F0 traces using a custom Matlab script. The software first 
smoothed the traces by applying Savitzky-Golay filtering (polynomial order: 7; frame length: 31 for 5 Hz acquisi-
tions and 207 for 33 Hz acquisitions) then ran findpeaks function with 0.02 ΔF/F0 minimum peak prominence as 
a threshold, to measure the number of peaks in the trace along with their maximum ΔF/F0 value. Tail movement 
analysis was first performed with ImageJ using a parabolic line selection with its focus centred on the tail posi-
tion at rest. The intensity line profile of the selection was then measured in each frame and the coordinate of the 
maximum intensity point indicated the tail position at that time. Tail position values were then converted in mm.
On tail movement traces peak analysis was also performed, by setting the minimum peak prominence to 
0.05 mm and the minimum peak distance to 0.3 s, as a threshold. These parameters were chosen to optimize true 
motion detection above noise.
Correlation plots shown in Fig. 5 were obtained by plotting against each other ΔF/F0 from two chosen regions. 
To distinguish fluorescence data occurring simultaneously with tail movement from those during rest, the tail 
position data were smoothed (running window of 150 points) and a threshold of 0.1 mm displacement of the tail 
was chosen to indicate significant movement.
Cross-correlation analysis shown in Fig. S1 was performed on brain recordings of larvae exposed to different 
PTZ concentrations, considering the four brain regions used throughout the paper and further dividing the data 
into the two hemispheres. For each condition considered, analysis was conducted on three progressive time-
frames along a one-hour measurement. Correlation coefficients were calculated for any chosen pair of brain 
regions, averaged over three replicates and plotted in the cross-correlation matrix shown in the figure.
High-throughput analysis. The fluorescence recordings from the high-throughput measurements were analysed 
by selecting a region of interest (ROI) around each well and then running a custom ImageJ macro enabling paral-
lel measurement of the maximum grey level detected in each ROI (after subtraction of the background measured 
in each ROI in a region of 230 px2 away from the larva). For larva tracking, the x,y coordinates of the centre of 
mass were extracted from the ROI after thresholding the image so to measure only pixels attributable to the larva. 
The routine ran these measurements on each frame of the acquired video. Subsequently, intensity data were ana-
lysed to obtain ΔF/F0 traces as described above, while coordinates data were used to plot the larva trajectory and 
calculate its speed for each pair of frames.
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